Global Head, External Scientific Engagement jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 3 days ago

Global Head, External Scientific Engagement

AstraZeneca is a leading company in the BioPharmaceuticals Business Unit focused on transforming patient outcomes. The Global Head of External Scientific Engagement for Cardiovascular, Renal & Metabolism will lead the external scientific strategy and build partnerships to enhance AstraZeneca’s scientific leadership and evidence generation.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits

Responsibilities

Be responsible for the end-to-end external scientific engagement strategy, plan, and execution across KEE engagement, professional societies, advocacy groups, and external medical education providers, aligned to TA priorities and congress strategies—driving transparency, consistency, and measurable impact
Develop and drive a coherent and agile external presence that advances AstraZeneca’s scientific leadership agenda across CVRM, ensuring our voice is timely, data-driven, and trusted
Introduce novel solutions and creative models for external engagement that differentiate AstraZeneca, expand our reach, and accelerate evidence adoption in clinical practice
Build and lead a high-performing, strategically focused global ESE team; define role transparency and proficiency frameworks, implement succession planning, and deliver targeted upskilling to regional teams to ensure consistent global execution
Serve as a senior scientific point of contact for external engagement across BPM, R&D, TAs, regions, and markets; co-lead external scientific planning with TA Heads, Medical Evidence Leads, Publications, Policy, and Market Access to align priorities and improve value
Own all CVRM BPM ESE budgets; identify and partner with agencies and providers that elevate AstraZeneca’s scientific standing and deliver quality at pace
Ensure all activities, tools, and systems meet the highest ethical and compliance standards—embedding rigor, clarity, and accountability in everything we do

Qualification

Sophisticated Scientific DegreeTherapeutic Area ExperiencePharmaceutical Leadership ExperienceESE Strategy DevelopmentBudget ManagementCross-Functional LeadershipTeam LeadershipAgile External InterfaceOperational Excellence

Required

Sophisticated Scientific Degree (MBBS, PharmD, PhD, or MD) or equivalent education
A minimum of 7 years of meaningful experience in the Therapeutic Area
A minimum of 5 years of Pharmaceutical experience that includes leadership positions in Medical Affairs and/or R&D
Validated experience owning the end-to-end ESE strategy, plan, and execution across KEE engagement, professional societies, advocacy groups, and external medical education providers, aligned to TA priorities and congress strategies
Confirmed ability to develop and drive a unified, agile external interface that advances scientific leadership in CVRM
Experience building and leading a strategically focused global ESE team, including defining role clarity and proficiency frameworks, succession planning, and targeted upskilling for regional teams
Cross-functional leadership experience serving as a senior scientific point of contact across BPM, R&D, TAs, regions, and markets; co-leading external scientific planning with TA Heads, Medical Evidence Leads, Publications, Policy, and Market Access
Experience owning CVRM BPM ESE budgets and partnering with agencies and providers to improve scientific standing

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Executive Director and Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase